
zzso therapy has been used clinically for over 60 years, yet continues to be problematic because of its narrow therapeutic index and large zzso zzso in patient zzso As a result, zzso is a leading cause of serious zzso adverse events, and its efficacy is also zzso 

To review factors that are responsible for variable response to zzso including clinical, zzso and genetic factors, and to explore some possible approaches to improving zzso zzso 

Recent efforts have focused on developing dosing zzso that included genetic information to try to improve zzso zzso These dosing zzso hold promise, but have not been fully validated or tested in rigorous clinical zzso Perhaps equally importantly, adherence to zzso is a major problem that should be addressed with innovative and cost-effective zzso 

Additional research is needed to further test whether interventions can be used to improve zzso dosing and zzso 

